A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

November 8, 2022

Study Completion Date

November 8, 2022

Conditions

Corneal Epithelium Defect

Interventions

DRUG

lowe-dose ZKY001 eye drops

eye drops

DRUG

Medium-dose ZKY001 eye drops

eye drops

DRUG

placebo

eye drops

Trial Locations (1)

Eye & ENT Hospital of Fudan University, Shanghai

All Listed Sponsors

lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY